1.	PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen Phase: Phase III Type: Treatment Status: Closed Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: TBC-PAN-003, NCT00088660
2.	Phase II Pilot Study of Vaccination Comprising Recombinant Vaccinia-CEA-MUC-1-TRICOM Vaccine, Recombinant Fowlpox-CEA-MUC-1-TRICOM Vaccine, and Sargramostim (GM-CSF) in Adults With Metastatic Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0246, 6536, NCI-6536, NCT00091000
3.	Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: Pro00007616, DUMC-5883-04-6RO, CDR000041079, 8087, NCT00103142
4.	Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 to 85 Sponsor: NCI Protocol IDs: 050229, 05-C-0229, NCI-05-C-0229, 6977, NCI-6977, NCT00217750, NCT00179309